 serum tumor marker patient alloc good-risk poor-risk clinic trial patient germ cell tumor alloc patient advanc germ cell tumor gct differ treatment program clinic characterist standard design clinic trial today studi substanti differ entri criteria differ outcom clinic trial factor differ clear due patient select bias unselect consecut patient good-risk poor-risk treatment program memori sloan-kett cancer center mskcc risk statu indiana univers IU classif result southeastern cancer studi group secsg result criteria substanti agreement total end result identif good-risk patient result poor-risk patient patient poor-risk mskcc criteria indiana criteria major discrep IU stage patient complet respons major factor differ risk assign use serum tumor marker serum tumor marker risk assign criteria gct clinic trial number good-risk gct patient poor-risk trial